Utah Medical Products Inc

Utah Medical Products Inc(UTMD)股票分析

$72.210

+2.260 (+3.13%)收盘时

Loading chart…
最高
73.350
开盘
70.590
成交量加权均价
72.05
成交量
51.33K
市值
235.88M
最低
70.590
成交额
3.70M
企业价值/息税折旧摊销前利润(TTM)
0.00

Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices.

AI 分析 of Utah Medical Products Inc (UTMD)

持有

Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.

估值指标

Utah Medical Products Inc(UTMD)当前预期市盈率为 13.04,5 年平均预期市盈率为 2.21。

预期市盈率

严重高估
5 年均值 P/E
2.21
当前P/E
13.04
高估
7.12
低估
-2.69

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 UTMD 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%UTMD

$61.55

情景价格

基

基准

基准 · 50%UTMD

$52.40

情景价格

悲

悲观

悲观 · 25%UTMD

$44.83

情景价格

事件时间线

2026-11-03 (ET)

10:30:00

Utah Medical Products Announces Quarterly Cash Dividend of $0.315

2026-10-29 (ET)

09:00:00

Utah Medical Products to Repurchase Up to 650,000 Shares at $75 Each

2026-10-22 (ET)

09:30:00

Company Reports Revenue of $8.6M, Down from $9.8M Last Year

2026-10-05 (ET)

09:00:00

Utah Medical Products Extends Stock Buyback to October 27

2026-09-24 (ET)

17:00:00

Utah Medical Products to Buy Back 650,000 Shares at $75 Each

资讯

UTMD 常见问题 —— 由 Alphio AI 解答

Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易